New York A05285 allows prescription labels for mifepristone or misoprostol to include the address of the prescribing health care practice at the.

New York A05285 amends the education law and public health law to allow prescription labels for mifepristone or misoprostol to include the address of the prescribing health care practice at the prescriber's request. It also mandates that prescribers inform patients if the label includes the practice's address instead of the prescriber's name. This change applies to both the dispensing and prescribing health care practices. The bill also adds a new section to the public health law requiring patient notification of any such label changes.

New York A05285 allows prescription labels for mifepristone or misoprostol to include the address of the prescribing health care practice at the.

New York A05285 amends the education law and public health law to allow prescription labels for mifepristone or misoprostol to include the address of the prescribing health care practice at the prescriber's request. It also mandates that prescribers inform patients if the label includes the practice's address instead of the prescriber's name. This change applies to both the dispensing and prescribing health care practices. The bill also adds a new section to the public health law requiring patient notification of any such label changes.